Satellite Symposium:
Combating Multidrug-Resistant Organisms: Strategic Considerations for Optimal Clinical Outcomes (Not Offical IDWeek Programming - This activity is supported by educational grants from Allergan, Inc; Cempra Pharmaceuticals, Inc; Tetraphase Pharmaceuticals, Inc; and The Medicines Company - See Affiliated Events Guide)
Wednesday, October 26, 2016: 8:30 AM-11:00 AM
Room: 293-296

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the official program IDWeek 2016 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposia, Presentation Theater, or Learning Lounge.

Faculty:

Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP (Chair)

Chair, Division of Infectious Disease

Summa Health

Akron, OH

Professor, Internal Medicine

Master Teacher and Chair,

Infectious Disease Section

Northeast Ohio Medical University

Rootstown, OH

George H. Karam, MD

Paula Garvey Manship Chair of Medicine

LSU School of Medicine in New Orleans

Department of Medicine

Section on Infectious Diseases

Baton Rouge, LA

 

James S. Lewis II, PharmD, FIDSA

Infectious Diseases Pharmacy Supervisor

Co-Director of Antibiotic Stewardship

Oregon Health and Science University

Departments of Pharmacy & Infectious Diseases

Portland, OR

 

Hans H. Liu, MD, FACP

Professor of Medicine

Sidney Kimmel School of Medicine

Thomas Jefferson University

Department of Medicine

Philadelphia, PA

Learning Objectives:

Upon proper completion of this activity, participants should be better able to:

  • Review pathogens responsible for most multidrug-resistant organism-related infections and their appropriate treatment.

  • Outline the appropriate integration of new and emerging antibiotics, alongside older, more established agents.

  • Summarize the tenets of effective antimicrobial stewardship, including the rationale, different interventions, and approaches to measuring process and outcomes.

 

This activity is provided by Paradigm Medical Communications, LLC. 

 

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation and Designation Statement

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. (Universal Activity Number 0761-9999-16-233-L01-P)

This is a knowledge-based activity.

Agenda subject to change and was provided by:

Paradigm Medical Communication, LLC; 523 Route 303; Orangeburg, NY; (845)398-5942; (845)398-5108;mrivera-placido@paradigmmc.com

This activity is jointly provided by Educational Review Systems, Inc. and Paradigm Medical Communications, LLC.

          

 

Please contact Marisol Rivera-Placido directly at (877) 252-5100, ext 1 ormrivera-placido@paradigmmc.comfor more information.

Target Audience: Academicians

Presentations:
8:30 AM
Registration and Complimentary Buffet Breakfast
9:00 AM
Clinical Program

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.